Global Initiatives: Explore a selection of ACC's 100+ programs held in 40+ countries
Explore tools and resources that speak to local needs around the globe
Global Initiatives: Explore tools and resources that speak to local needs around the globe
Membership: Join over 56,000 members from over 140 countries
Join over 56,000 members from over 140 countries
Membership: Join over 56,000 members from over 140 countries
JACC Journals: Stay Up to Date on the Latest from JACC Journals
Stay Up to Date on the Latest from JACC Journals
JACC Journals: Stay Up to Date on the Latest from JACC Journals; Click here to learn more!
The ACC invites you to move into an era of global collaboration; Click here to learn more!
The ACC invites you to move into an era of global collaboration
The ACC invites you to move into an era of global collaboration; Click here to learn more!
Education: Explore localized education with actionable insights for your practice
Explore localized education with actionable insights for your practice
Education: Explore localized education with actionable insights for your practice
Guidelines: Get the latest guidelines in 21+ clinical topic hubs
Get the latest guidelines in 21+ clinical topic hubs
Guidelines: Get the latest guidelines in 21+ clinical topic hubs

ACC Sessions at the European Society of Cardiology Congress (ESC) 2022

The Ischemia Trial: Lessons for Today's Management of Coronary Artery Disease
August 28 at 08:30 CEST

Chairpersons: Franz Weidinger, MD, FACC; Michael Valentine, MD, MACC; Dipti Itchhaporia, MD, MACC

The Ischemia Trial in a Nutshell: Rationale, Design and Major Results

The Imager's Perspective on the Ischemia Trial

The Interventionalist's Perspective on the Ischemia Trial

Gender Issues in CCS and the Ischemia Trial

The Ischemia Trial: Putting it All Together in 2022

Panel Discussion

AMGEN
Biosense Webster a part of the Johnson and Johnson Family of Companies
Edwards Lifesciences Foundation
Novartis
Novo Nordisk
pfizer
Philips
Siegfried Rhein
Sun Pharma
Viatris